IL33 and eosinophilic esophagitis: In order to validate our findings of PBMC composition and activation, we utilized a novel inducible mouse model of EoE, where disease pathology is induced under doxycycline exposure leading to increased secretion of the active form of IL-33 in the esophagus (23).